Free fatty acid receptor 1 (FFAR1), also known as GPR40, has garnered significant interest as a therapeutic target in type 2 diabetes. Agonists of this receptor stimulate insulin secretion from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback